Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests

[1]  V. Wong,et al.  Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores , 2022, Journal of hepatology.

[2]  V. de Lédinghen,et al.  Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD , 2022, Hepatology.

[3]  M. Noureddin,et al.  Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD‐related cirrhosis , 2022, Hepatology.

[4]  B. Neuschwander‐Tetri,et al.  Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD) , 2022, Alimentary pharmacology & therapeutics.

[5]  Jakob Nikolas Kather,et al.  Artificial intelligence in liver diseases: Improving diagnostics, prognostics and response prediction , 2022, JHEP reports : innovation in hepatology.

[6]  B. Neuschwander‐Tetri,et al.  Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease. , 2021, The New England journal of medicine.

[7]  J. Danesh,et al.  SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. , 2021, European heart journal.

[8]  M. Friedrich-Rust,et al.  Easl Clinical Practice Guidelines (Cpgs) On Non-Invasive Tests For Evaluation Of Liver Disease Severity And Prognosis- 2020 Update. , 2021, Journal of hepatology.

[9]  V. Wong,et al.  Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis , 2021, Gut.

[10]  A. Khosla,et al.  A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH , 2021, Hepatology.

[11]  F. Anania,et al.  Nonalcoholic Steatohepatitis: Current Thinking From the Division of Hepatology and Nutrition at the Food and Drug Administration , 2020, Hepatology.

[12]  E. Tsochatzis,et al.  Case-finding strategies in non-alcoholic fatty liver disease , 2020, JHEP reports : innovation in hepatology.

[13]  P. Bossuyt,et al.  Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis. , 2020, Journal of hepatology.

[14]  N. Bhala,et al.  Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis. , 2020, Gastroenterology.

[15]  D. Thorburn,et al.  Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease. , 2019, Journal of hepatology.

[16]  V. de Lédinghen,et al.  New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD. , 2019, Journal of hepatology.

[17]  M. Ekstedt,et al.  Collagen proportionate area is an independent predictor of long‐term outcome in patients with non‐alcoholic fatty liver disease , 2019, Alimentary pharmacology & therapeutics.

[18]  M. Allison,et al.  Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. , 2019, Gastroenterology.

[19]  P. Schirmacher,et al.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.

[20]  S. Bertrais,et al.  Screening for therapeutic trials and treatment indication in clinical practice: MACK‐3, a new blood test for the diagnosis of fibrotic NASH , 2018, Alimentary pharmacology & therapeutics.

[21]  M. Abecassis,et al.  AASLD guidelines for the treatment of hepatocellular carcinoma , 2018, Hepatology.

[22]  Lunan Yan,et al.  Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta‐analysis , 2017, Hepatology.

[23]  M. Kudo,et al.  Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update , 2017, Hepatology International.

[24]  G. Collins,et al.  Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement , 2015, BMC Medicine.

[25]  Gary S Collins,et al.  Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement , 2015, BMC Medicine.

[26]  P. Bedossa.  Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease , 2014, Hepatology.

[27]  M. Bulsara,et al.  Image analysis of liver biopsy samples measures fibrosis and predicts clinical outcome. , 2014, Journal of hepatology.

[28]  P. Calès,et al.  Quantification of portal–bridging fibrosis area more accurately reflects fibrosis stage and liver stiffness than whole fibrosis or perisinusoidal fibrosis areas in chronic hepatitis C , 2014, Modern Pathology.

[29]  S. Bertrais,et al.  Optimization and robustness of blood tests for liver fibrosis and cirrhosis. , 2010, Clinical biochemistry.

[30]  A. Sanyal,et al.  Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[31]  T. Therneau,et al.  The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD , 2007, Hepatology.

[32]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[33]  G. Práctica,et al.  European Association for the Study of the Liver , 1971 .

[34]  John Lavagnino,et al.  Access , 2009, Lit. Linguistic Comput..

[35]  G. Hunault,et al.  Reproducibility of blood tests of liver fibrosis in clinical practice. , 2008, Clinical biochemistry.

[36]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..